TBPH

News Theravance Sales Jump 83 Percent

14d ago

News Here's Why You May Invest in Theravance (TBPH) Stock Now

14d ago

News AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer

14d ago

News Wall Street Analysts Predict a 90.53% Upside in Theravance Bio (TBPH): Here's What You Should Know

14d ago

SEC filing TBPH Reports $17.7M YUPELRI Rev, $873M TRELEGY Sales, $395M Cash, $20M Milestone Target, 20% OpExp Cut, All Hatch-Waxman Litigation Resolved

26d ago

News Summers Value Fund adds TBPH, exits ADMA among Q1 moves

34d ago

SEC filing TBPH Reports $266.6M YUPELRI Sales, $3.9B TRELEGY, $50M Milestone, $400M Cash, No Debt

75d ago

Insider trade Sale by Rhonda Farnum (SVP, COMM & MEDICAL AFFAIRS)

75d ago

News Theravance Biopharma Plummets As Phase 3 Study Falls Short

90d ago

News Theravance drops rare disease drug after late-stage trial setback

91d ago

News AstraZeneca To Delist ADRs From Nasdaq By January, Eyes Broader Investor Reach

132d ago

News Neurogenic Orthostatic Hypotension (nOH) Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

134d ago

News Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease

153d ago

News Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

153d ago

Scanner Unusual volume (z=2.6)

161d ago

Scanner Unusual volume (z=2.6)

163d ago

Scanner Unusual volume (z=2.6)

164d ago